Summary
Overview
Work History
Education
Skills
Certification
Honors and Awards
Publications
Presentations
Professional Service
Additional training
Timeline
Generic

Kelly MS Hugunin

West Springfield,VA

Summary

Division Special Assistant for Signal Detection and Management with 10 years of experience in pharmacovigilance at FDA-CVM. As subject matter expert on disproportionality analysis, integrated data mining into FDA-CVM's adverse drug event review processes, enabling improved safety review for all regulated veterinary products without increased resources. Consistently demonstrate expertise in identifying, investigating, and communicating emerging safety issues to internal colleagues and external stakeholders, including industry and other regulatory agencies, both foreign and domestic. Provide valuable guidance and coaching to safety reviewers on signal detection and risk communication. Nine years serving as the agency expert on the Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) Subcommittee focusing on enhancements which improve signal detection. Previous experience in generic animal drug approvals at the FDA, comparative animal medicine at the NIH and academia, epidemiology, and biostatistics.

Overview

28
28
years of professional experience
1
1
Certification

Work History

Veterinary Officer, Pharmacovigilance Specialist

US Food and Drug Administration
08.2015 - Current
  • Center for Veterinary Medicine, Office of Surveillance and Compliance
  • Currently serve as a Veterinary Medical Officer in the role of Division Special Assistant for Signal Detection and Management and Data Mining Coordinator for the Division of Pharmacovigilance and Surveillance (DPS)
  • Develop, coordinate, implement, and document standardized procedures (SOPs and Policy and Procedures documents) for the review of adverse event report data for traditional regulated veterinary drug products, incorporating disproportionality analysis into these procedures
  • Advise safety reviewers within DPS in the development and completion of adverse event data analyses and reviews
  • Perform disproportionality analysis (data mining) to identify important safety signals for regulated veterinary drug products
  • Perform adverse event data reviews as requested from within the Division, Office, or Center
  • Maintain and improve CVM specific internal terms for standardized coding of adverse events
  • Serve as FDA representative to collaborate with international community to maintain and improve accepted standardized coding for veterinary medical adverse events (VeDDRA)
  • Serve as needed as subject matter expert for pharmacovigilance to improve the ability of CVM to assess the safety and efficacy of regulated veterinary drug products
  • Provided consultation of the Office of New Animal Product Evaluation (ONAPE) on postapproval requirements for new animal drug applications involving intentionally genetically engineered animals


Veterinary Medical Officer

Food and Drug Administration
08.2012 - 08.2015
  • Center for Veterinary Medicine, Office of New Animal Drug Evaluation
  • Served as a Veterinary Medical Officer on Review Team 2 (HFV-172) in the Division of Generic Animal Drugs
  • Assessed information submitted by drug sponsors as part of the approval process for generic animal drugs
  • Produced scientific reviews for pivotal bioequivalence studies, bioequivalence waivers, and analytical methods submissions
  • Participated in working group for development of question-based review for protocols and data submissions relevant to generic animal applications
  • Provided consulting guidance on animal use and welfare for several proposals submitted to CBER under the Animal Rule


Staff Scientist, Clinical Veterinarian

National Institutes of Health
07.2009 - 07.2012


  • Served as a veterinarian in the Division of Veterinary Resources on both the Poolesville and Bethesda campuses of NIH
  • Provided clinical, preventative and surgical care to a diverse number of animal species (including rats, mice, old and new world primates, pigs, sheep, guinea pigs, and rabbits)
  • Reviewed animal use protocols
  • Provided consultation and training in humane care of animals used in biomedical research including applicable laws and regulations to investigators, technicians and students
  • Developed and revised various standard operating procedures relevant to an animal care program
  • Provided oversight for rodent health surveillance program
  • Participated in local and national meetings for laboratory animal science


Research Assistant

Johns Hopkins School of Public Health
01.2005 - 01.2006
  • Performed statistical analysis and data management for a large-scale longitudinal study of injection drug users

Undergraduate and Graduate Research Assistant

University of North Carolina at Chapel Hill
01.1997 - 01.2005
  • School of Public Health, Biometric Consulting Laboratory
  • Performed statistical analysis, consulting, and data management for various health science related projects


Statistical Consultant

North Carolina State University
01.2002 - 01.2004
  • College of Veterinary Medicine, Department of Clinical Science
  • Performed statistical analysis and data management for a multi-year morphometric study of coyotes and red wolves

Education

Postdoctoral Fellowship - Comparative Medicine

University of Michigan
Ann Arbor, MI
07-2009

Bachelor of Science - Public Health - Biostatistics

University of North Carolina At Chapel Hill
Chapel Hill, NC
05-1999

Doctor of Veterinary Medicine -

North Carolina State University
Raleigh, NC
05-2005

Masters of Public Health - Biostatistics

University of North Carolina At Chapel Hill
Chapel Hill, NC
12-2003

Skills

  • Pharmacovigilance subject matter expert
  • Signal detection and management lead
  • Coach safety officers on review of emerging safety issues
  • Adverse drug event evaluation and causality assessment
  • Scientific and technical report writing and editing
  • Development and review of SOPs and Policy and Procedure documents
  • Adverse drug event coding dictionary (VeDDRA) expertise
  • Biostatistics and epidemiology
  • Comparative animal medicine

Certification

American College of Laboratory Animal Medicine 2010 – retired 2017


North Carolina Veterinary Medical Board

2005

Honors and Awards

FDA Group Recognition Award (Non-agency Crosscutting)    2023

OSC’s Office Quality Committee


CVM Excellence in Veterinary Public Health Award     2021

Novel Animal Biotech Product Approval Team


CVM Team Excellence Award        2021

Isoxazoline Review Team


FDA Group Recognition Award (Non-agency Crosscutting)    2016

Generics Question Based Review (QbR) Working Group


FDA Outstanding Service Award        2015

Electronic Document Submission and Review Group


Association of Primate Veterinarians       2007

Student Travel Award


NCSU, College of Veterinary Medicine       2005

Excellence in Wildlife Medicine


Society of Phi Zeta          2004

Member Induction


Delta Omega Honor Society in Public Health      1999

Honorary Membership


Publications

Cotroneo T, Hugunin K, Shuster K, Hwang H, Kakaraparthi B, Nemzek J.  2012.  Effects of buprenorphine on cecal ligation and puncture models in C57BL/6 mice.  J Am Assoc Lab Anim Sc 51(3): 357-65.


Nowland MH, Hugunin KMS, Rogers KL.  2011.  Effects of short term fasting in male Sprague Dawley rats.  Comp Med 61(2): 138-44.


Hugunin KMS, Fry C, Shuster K, Nemzek JA.  2010.  Effects of tramadol and buprenorphine on select immunologic factors in a cecal ligation and puncture model.  Shock 34(3): 250-60.


Lee J, Lee CS, Hugunin KM, Maute CJ, Dysko RC.  2010.  Bacteria from drinking water supply and their fate in gastrointestinal tracts of germ-free mice: a phylogenetic comparison study.  Water Res 44(17): 5050-8.


Nemzek JA, Hugunin KM, Opp MR.  2008.  Modeling sepsis in the laboratory: merging sound science with animal well-being.  Comp Med 58(2): 120-8.


Meier TR, Maute CJ, Cadillac JM, Lee JM, Righter DJ, Hugunin KM, Deininger RA, Dysko RC.  2008.  Quantification, distribution, and possible source of bacterial biofilm in mouse automated watering systems.  J Am Assoc Lab Anim Sci 47(2): 63-70.


Duran-Struuck, Hartigan A, Clouthier SG, Dyson MC, Lowler K, Gatza E, Tawara I, Toubai T, Weisiger E, Hugunin K, Reddy P, Wilkinson JE.  2008.  Differential susceptibility of C57BL/6NCr and B6.Cg-Ptprca mice to commensal bacteria after whole body irradiation in translational bone marrow transplant studies.  J Transl Med 6: 10-22.


Hall AJ, Hugunin K, Deaville R, Law RJ, Allchin CR, Jepson PD.  2006.  The risk of infection from polychlorinated biphenyl exposure in the harbor porpoise (Phocoena phocoena): a case-control approach.  Environ Health Perspect 114(5): 704-11.

Presentations

Hugunin K, Duggirala H. FDA-CVM Talent Development and Learning Center. Rockville, MD. September 24, 2019. “Epidemiological Applications to the Post-Approval Setting: Principles of epidemiology and its applications at FDA-CVM.”


Walter-Grimm L, Hugunin K, Palmer LA.  Animal Health Institute, Pharmacovigilance Workshop. Rockville, MD, October 25, 2016. “Early experience with adverse drug event signal detection and management at CVM.”


Case report presentation at the 62nd annual meeting of the American Association of Laboratory Animal Science.  San Diego, CA, October 4, 2011.  “Periocular abnormalities in an SIV-infected rhesus macaque.”


Poster at the American College of Laboratory Animal Medicine Forum (Invited).  Newport, RI, May 2-5, 2010.  “Effects of buprenorphine and tramadol on select immunologic parameters in a cecal ligation and puncture model.”


Poster at the 60th annual meeting of the American Association of Laboratory Animal Science.  Denver, CO, November 11, 2009.  “Colonization of abiotic mice by biofilm bacteria.”


Poster at the 32nd annual Conference on Shock hosted by the Shock Society.  San Antonio, TX, June 7, 2009.  “Immunologic effects of opioid analgesia in a cecal ligation and puncture model of sepsis.”


Poster at the 59th annual meeting of the American Association of Laboratory Animal Science.  Indianapolis, IN, November 11, 2008.  “The effect of reverse osmosis, deionization, and ultraviolet filtration on biofilm development in automated watering manifolds.”


Case report presentation at the 2007 Annual Workshop of the Association of Primate Veterinarians.  Charlotte, NC, October 11, 2007.  “Acute anorexia and lethargy associated with pyrexia in an adult rhesus macaque”.


“What’s your diagnosis” presentation at the 58th annual meeting of the American Association of Laboratory Animal Science.  Charlotte, NC, October 16, 2007.  “Weight loss and anorexia in a guinea pig.”


“What’s your diagnosis” presentation at the 58th annual meeting of the American Association of Laboratory Animal Science.  Charlotte, NC, October 16, 2007.  “Acute anorexia and lethargy associated with pyrexia in an adult rhesus macaque”.

Professional Service

American Association for Laboratory Animal Science

  • Editorial Review Board 2014 -2017
  • Ad hoc reviewer 2010 – 2014

Additional training

DC Academy of Veterinary Medicine      2012-Present

Veterinary Seminar Series

Fairfax, VA


CL Davis DVM Foundation         2010

Workshop and Symposium on Laboratory Animal Diseases

Chicago, IL


CL Davis DVM Foundation & NC Association of Laboratory Animal Medicine  2010

Workshop in Laboratory Animal Medicine

Raleigh, NC


Air Force Institute of Pathology        2009

Pathology of Laboratory Animals

Bethesda, MD


Charles River Laboratories         2008

Short Course (in Laboratory Animal Topics)

Newton, MA


Johns Hopkins University, Bloomberg School of Public Health      2005-2006

Doctor of Philosophy courses (degree not conferred, left in excellent academic standing after one year to pursue post-doctoral fellowship)

Baltimore, MD


Centers for Disease Control and Prevention      2004

Epidemic Intelligence Service Elective for Senior Veterinary and Medical Students

Atlanta, GA and Taft, CA


Sea Mammal Research Unit        2003, 2004

One month externships performing laboratory, statistical, and field investigations involving immunologic aspects of marine mammals

St. Andrews, Scotland

Timeline

Veterinary Officer, Pharmacovigilance Specialist

US Food and Drug Administration
08.2015 - Current

Veterinary Medical Officer

Food and Drug Administration
08.2012 - 08.2015

Staff Scientist, Clinical Veterinarian

National Institutes of Health
07.2009 - 07.2012

Research Assistant

Johns Hopkins School of Public Health
01.2005 - 01.2006

Statistical Consultant

North Carolina State University
01.2002 - 01.2004

Undergraduate and Graduate Research Assistant

University of North Carolina at Chapel Hill
01.1997 - 01.2005

Postdoctoral Fellowship - Comparative Medicine

University of Michigan

Bachelor of Science - Public Health - Biostatistics

University of North Carolina At Chapel Hill

Doctor of Veterinary Medicine -

North Carolina State University

Masters of Public Health - Biostatistics

University of North Carolina At Chapel Hill
Kelly MS Hugunin